UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate

Circulation (New York, N.Y.), 2015-01, Vol.131 (1), p.82-90

2015

Volltextzugriff (PDF)

Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2019-12, Vol.78 (12), p.1609

2019

Volltextzugriff (PDF)

The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn’s disease: a post hoc analysis

Alimentary pharmacology & therapeutics, 2019-01, Vol.49 (2), p.155-164

2019

Volltextzugriff (PDF)

Coronary heart disease in HIV-infected individuals

Journal of acquired immune deficiency syndromes (1999), 2003-08, Vol.33 (4), p.506

2003

Volltextzugriff (PDF)

Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity : demonstrable differences in vitro and clinically

AIDS (London), 2006-09, Vol.20 (14), p.1813-1821

2006

Volltextzugriff (PDF)

Treatment with Adenosine Diphosphate Receptor Inhibitors—Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study design: Expanding the paradigm of longitudinal observational research

The American heart journal, 2011-11, Vol.162 (5), p.844-851

2011

Volltextzugriff (PDF)

Efficacy/Safety of a Fixed‐Dose Amlodipine/Olmesartan Medoxomil–Based Treatment Regimen in Hypertensive Blacks and Non‐Blacks With Uncontrolled BP on Prior Antihypertensive Monotherapy

The journal of clinical hypertension (Greenwich, Conn.), 2013-04, Vol.15 (4), p.247-253

2013

Volltextzugriff (PDF)

The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel: The PARADOX Study

Journal of the American College of Cardiology, 2013-08, Vol.62 (6), p.505-512

2013

Volltextzugriff (PDF)

Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data

Inflammatory bowel diseases, 2018-04, Vol.24 (5), p.932-942

2018

Volltextzugriff (PDF)

Efficacy of Amlodipine and Olmesartan Medoxomil in Hypertensive Patients With Diabetes and Obesity

The journal of clinical hypertension (Greenwich, Conn.), 2011-06, Vol.13 (6), p.422-430

2011

Volltextzugriff (PDF)

The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel

Journal of the American College of Cardiology, 2013-08, Vol.62 (6), p.505-512

2013

Volltextzugriff (PDF)

Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies

Journal of Crohn's and colitis, 2019-05, Vol.13 (6), p.725-734

2019

Volltextzugriff (PDF)

Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients

Journal of acquired immune deficiency syndromes (1999), 2009-06, Vol.51 (2), p.163

2009

Volltextzugriff (PDF)

Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials

Journal of Crohn's and colitis, 2018-07, Vol.12 (8), p.930-938

2018

Volltextzugriff (PDF)

Phenotypic Susceptibility to Didanosine Is Associated with Antiviral Activity in Treatment-Experienced Patients with HIV-1 Infection

The Journal of infectious diseases, 2007-02, Vol.195 (3), p.392-398

2007

Volltextzugriff (PDF)

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies

Advances in therapy, 2018-04, Vol.35 (4), p.563-576

2018

Volltextzugriff (PDF)

Efficacy of Amlodipine/Olmesartan ± Hydrochlorothiazide in Patients Uncontrolled on Prior Calcium Channel Blocker or Angiotensin II Receptor Blocker Monotherapy

Advances in therapy, 2012-06, Vol.29 (6), p.508-523

2012

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of the Nonvitamin K Antagonist Oral Anticoagulant Edoxaban When Administered Alone or After Switching from Rivaroxaban or Dabigatran Etexilate in Healthy Subjects

Clinical drug investigation, 2016-02, Vol.36 (2), p.127-136

2016

Volltextzugriff (PDF)

Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy

Current medical research and opinion, 2012-11, Vol.28 (11), p.1809-1818

2012

Volltextzugriff (PDF)

Host factors may be more important than choice of antiretrovirals in the development of lipoatrophy

The AIDS reader, 2003-11, Vol.13 (11), p.539

2003

Volltextzugriff (PDF)

Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy

Therapeutic advances in cardiovascular disease, 2012-08, Vol.6 (4), p.149-161

2012

Volltextzugriff (PDF)

Efficacy of Amlodipine/Olmesartan Medoxomil ± Hydrochlorothiazide in Patients Aged ≥ 65 or < 65 Years With Uncontrolled Hypertension on Prior Monotherapy

Postgraduate medicine, 2013-03, Vol.125 (2), p.124-134

2013

Volltextzugriff (PDF)

Blood Pressure-Lowering Efficacy of an Olmesartan Medoxomil/Hydrochlorothiazide-Based Treatment Algorithm in Elderly Patients (Age ≥65 Years) Stratified by Age, Sex and Race: Subgroup Analysis of a 12-Week, Open-Label, Single-Arm, Dose-Titration Study

Drugs & aging, 2011-06, Vol.28 (6), p.477-490

2011

Volltextzugriff (PDF)

Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study

Therapeutic advances in cardiovascular disease, 2010-08, Vol.4 (4), p.209-221

2010

Volltextzugriff (PDF)

Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion

Journal of acquired immune deficiency syndromes (1999), 2005-06, Vol.39 (2), p.181

2005

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(44)
Dissertationen
(1)

Sprache

Englisch
(45)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(26)
Science & Technology
(25)
Male
(24)
Female
(23)
Life Sciences & Biomedicine
(23)
Middle Aged
(20)
Adult
(18)
Aged
(13)
Drug Therapy, Combination
(10)
Olmesartan Medoxomil
(10)
Hypertension - Drug Therapy
(9)
Biological And Medical Sciences
(8)
Hypertension
(8)
Medical Sciences
(8)
Pharmacology & Pharmacy
(8)
Treatment Outcome
(8)
Antihypertensive Agents - Therapeutic Use
(7)
Blood Pressure - Drug Effects
(7)
Drug Therapy
(7)
Imidazoles - Therapeutic Use
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate

Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis

The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn’s disease: a post hoc analysis

Coronary heart disease in HIV-infected individuals

Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity : demonstrable differences in vitro and clinically

Treatment with Adenosine Diphosphate Receptor Inhibitors—Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study design: Expanding the paradigm of longitudinal observational research

Efficacy/Safety of a Fixed‐Dose Amlodipine/Olmesartan Medoxomil–Based Treatment Regimen in Hypertensive Blacks and Non‐Blacks With Uncontrolled BP on Prior Antihypertensive Monotherapy

The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel: The PARADOX Study

Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data

Efficacy of Amlodipine and Olmesartan Medoxomil in Hypertensive Patients With Diabetes and Obesity

The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel

Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies

Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients

Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials

Phenotypic Susceptibility to Didanosine Is Associated with Antiviral Activity in Treatment-Experienced Patients with HIV-1 Infection

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies

Efficacy of Amlodipine/Olmesartan ± Hydrochlorothiazide in Patients Uncontrolled on Prior Calcium Channel Blocker or Angiotensin II Receptor Blocker Monotherapy

Pharmacokinetics and Pharmacodynamics of the Nonvitamin K Antagonist Oral Anticoagulant Edoxaban When Administered Alone or After Switching from Rivaroxaban or Dabigatran Etexilate in Healthy Subjects

Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy

Host factors may be more important than choice of antiretrovirals in the development of lipoatrophy

Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy

Efficacy of Amlodipine/Olmesartan Medoxomil ± Hydrochlorothiazide in Patients Aged ≥ 65 or < 65 Years With Uncontrolled Hypertension on Prior Monotherapy

Blood Pressure-Lowering Efficacy of an Olmesartan Medoxomil/Hydrochlorothiazide-Based Treatment Algorithm in Elderly Patients (Age ≥65 Years) Stratified by Age, Sex and Race: Subgroup Analysis of a 12-Week, Open-Label, Single-Arm, Dose-Titration Study

Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study

Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion

Suchergebnisse filtern